Gaganyaan Mission not affected by COVID

Gaganyaan Mission not affected by COVID

New Delhi: Union Minister of State (Independent Charge) Development of North Eastern Region (DoNER), MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, Dr Jitendra Singh said that the launch of India’s first human space mission “Gaganyaan” will not be affected by COVID pandemic and preparation are carrying on in the right direction.

Briefing about the important achievements of Indian Space Research Organisation (ISRO) and the Department of Space over the last one year and some of the important missions planned for the future, Singh said that even though because of the COVID-19 pandemic, the training of four Indian astronauts in Russia had to be halted, yet the opinion of Chairman ISRO and the scientific team is that there had been kept a “cushion” both in the training programme and launch deadline. The training of astronauts has now been resumed and the launch is scheduled to take place as planned, before the 75th anniversary of India’s independence in 2022, he said.

Gaganyaan Mission not affected by COVID

Elaborating on the cabinet decision to encourage private participation in ISRO activities, Dr Jitendra Singh said, a regulatory body called “Indian National Space Promotion & Authorization Centre (IN-SPACe)” is to be established. This will help provide a level playing field to private players and encourage their participation, he said.

Gaganyaan Mission not affected by COVID

Singh said, besides enhancing the capacity and resources of the space missions, increased participation of private players will also discourage the brain drain of talented space scientists and experts who were otherwise moving out of India in search of a break.

About Chandrayaan-3 Lunar mission, he said that as of now, it is planned for launch next year. This mission will involve a lander, rover and a propulsion system to carry the modules to move but it would not have orbiter as the previous orbiter is fully operational, he added.

Related Articles

Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker